主

$BAO PHARMA-B(02659.HK) surged +21% on Thursday, with trading volume exceeding seven times the daily average, closing at…

$BAO PHARMA-B(02659.HK) surged +21% on Thursday, with trading volume exceeding seven times the daily average, closing at HKD 11.4.

Last week, the approval of BJ045 combined with the chairman's share purchases drove a weekly amplitude of over 40%. With no new announcements on Thursday, capital continued to push the price higher along the existing catalysts. Amid a day where Hong Kong tech stocks generally weakened, it stood out as one of the few small-cap biotechs seeing increased volume and solid buying support.

The stock pulled back to HKD 10.44 the next day as momentum traders took profits. The commercial ramp-up for BJ045 awaits subsequent sales data, but the market had already priced in the approval expectations.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.